Appraisal of treatment outcomes in integrative medicine using metabonomics: Taking non-alcoholic fatty liver disease with spleen deficiency syndrome as an example

Wang, 2017, Integration of traditional Chinese medicine and Western medicine in the era of precision medicine, J Integr Med, 15, 1, 10.1016/S2095-4964(17)60314-5 Dobos, 2011, The model of Western integrative medicine: the role of Chinese medicine, Chin J Integr Med, 17, 11, 10.1007/s11655-011-0601-x Sun, 2012, Chinese integrative medicine: translation toward person-centered and balanced medicine, Chin J Integr Med, 18, 3, 10.1007/s11655-012-0961-x Chan, 2020, COVID-19: An update on the epidemiological, clinical, preventive and therapeutic evidence and guidelines of integrative Chinese-Western medicine for the management of 2019 novel coronavirus disease, Am J Chin Med, 48, 737, 10.1142/S0192415X20500378 Ho, 2015, Using Chinese medicine in a Western way’: negotiating integrative Chinese medicine treatment for type 2 diabetes, Commun Med, 12, 41, 10.1558/cam.v12i1.25993 Hon, 2017, Complementary, alternative and integrative medicine for childhood atopic dermatitis, Recent Pat Inflamm Allergy Drug Discov, 11, 114, 10.2174/1872213X11666171128142333 Liao, 2020, Clinical Practice Guideline of Integrative Chinese and Western Medicine for Acute Myocardial Infarction Working Group. Clinical practice guideline of integrative Chinese and Western medicine for acute myocardial infarction, Chin J Integr Med, 26, 539, 10.1007/s11655-019-3154-z Millstine, 2017, Complementary and integrative medicine in the management of headache, BMJ, 357 Li, 2018, Consensus on diagnosis and treatment of ulcerative colitis by integrated Chinese and Western medicine, Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi, 26, 105 Tang, 2020, Consensus on diagnosis and treatment of chronic pancreatitis by integrated Chinese and Western medicine, Zhongguo Zhong Xi Yi Jie He Xiao Hua Za Zhi, 28, 731 Yu, 2017, Conception and framework of developing a system of disease-syndrome combined angina questionnaires for traditional Chinese medicine assessment, Zhonghua Zhong Yi Yao Xue Kan, 35, 1989 Wei, 2002, Rudimental investigation on fatty liver syndrome differentiation typing law, Liaoning Zhong Yi Za Zhi, 29, 655 Wei, 2009, Distribution pattern of traditional Chinese medicine syndromes in 793 patients with fatty liver disease, Zhong Xi Yi Jie He Xue Bao, 7, 411, 10.3736/jcim20090503 Dang, 2019, The traditional Chinese formulae Ling-gui-zhu-gan decoction alleviated non-alcoholic fatty liver disease via inhibiting PPP1R3C mediated molecules, BMC Compl Altern Med, 19, 8, 10.1186/s12906-018-2424-1 Dang, 2020, Ling-gui-zhu-gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine, Biomed Pharmacother, 127 Liu, 2013, Chinese medicine formula Lingguizhugan decoction improves beta-oxidation and metabolism of fatty acid in high-fat-diet-induced rat model of fatty liver disease, Evid Based Complement Alternat Med, 2013 Xu, 2020, Traditional Chinese medicine Lingguizhugan decoction treating non-alcoholic fatty liver disease with spleen-yang deficiency pattern: study protocol for a multicenter randomized controlled trial, Trials, 21, 512, 10.1186/s13063-020-04362-7 Wang, 2013, Traditional Chinese medicine ZHENG and omics convergence: a systems approach to post-genomics medicine in a global world, OMICS, 17, 451, 10.1089/omi.2012.0057 Zhang, 2013, Recent highlights of metabolomics in Chinese medicine syndrome research, Evid Based Complement Alternat Med, 2013, 10.1155/2013/402159 German, 2005, Metabolomics: building on a century of biochemistry to guide human health, Metabolomics, 1, 3, 10.1007/s11306-005-1102-8 Nicholson, 1999, “Metabonomics”: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data, Xenobiotica, 29, 1181, 10.1080/004982599238047 Jiang, 2012, Syndrome differentiation in modern research of traditional Chinese medicine, J Ethnopharmacol, 140, 634, 10.1016/j.jep.2012.01.033 Lu, 2012, An integrative approach of linking traditional Chinese medicine pattern classification and biomedicine diagnosis, J Ethnopharmacol, 141, 549, 10.1016/j.jep.2011.08.045 Zhang, 2017, Consensus of traditional Chinese medicine diagnosis and treatment of spleen deficiency syndrome (2017), Zhong Yi Za Zhi, 58, 1525 Acquadro, 2003, Incorporating the patient’s perspective into drug development and communication: an ad hoc task force report of the Patient-Reported Outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001, Value Health, 6, 522, 10.1046/j.1524-4733.2003.65309.x Basch, 2018, Implementation of patient-reported outcomes in routine medical care, Am Soc Clin Oncol Educ Book, 38, 122, 10.1200/EDBK_200383 Deng, 2013, 114 Zheng, 2002, 361 Hasson, 2000, Research guidelines for the Delphi survey technique, J Adv Nurs, 32, 1008, 10.1046/j.1365-2648.2000.t01-1-01567.x Powell, 2003, The Delphi technique: myths and realities, J Adv Nurs, 41, 376, 10.1046/j.1365-2648.2003.02537.x Bujang, 2018, A review on sample size determination for Cronbach’s alpha test: a simple guide for researchers, Malays J Med Sci, 25, 85 Cai, 2004, Development of osteoporosis quality of life scale and item selection, Zhongguo Xing Wei Yi Xue Ke Xue, 13, 221 Tang, 2009, Development and analysis of a patient reported outcome instrument for chronic gastrointestinal diseases, Zhong Yi Za Zhi, 50, 27 Dai, 2022, Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach, Front Med, 10.1007/s11684-021-0880-3 Zhang, 2021, Determining sample size of pilot trials in traditional Chinese medicine, Zhong Yi Za Zhi, 62, 307 Ferslew, 2015, Altered bile acid metabolome in patients with nonalcoholic steatohepatitis, Dig Dis Sci, 60, 3318, 10.1007/s10620-015-3776-8 MahmoudianDehkordi, 2019, Altered bile acid profile associates with cognitive impairment in Alzheimer’s disease—an emerging role for gut microbiome, Alzheimer’s Dement, 15, 76, 10.1016/j.jalz.2018.07.217 Xie, 2016, Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis, Int J Cancer, 139, 1764, 10.1002/ijc.30219 Pang, 2018, Serum metabolomics analysis of asthma in different inflammatory phenotypes: a cross-sectional study in northeast China, Biomed Res Int, 2018, 2860521, 10.1155/2018/2860521 Jin, 2003, 332 Chen, 2012, A network-based analysis of traditional Chinese medicine cold and hot patterns in rheumatoid arthritis, Complement Ther Med, 20, 23, 10.1016/j.ctim.2011.10.005 Holmes, 2008, Metabolic phenotyping in health and disease, Cell, 134, 714, 10.1016/j.cell.2008.08.026 Zhou, 2019, A large-scale, multi-center urine biomarkers identification of coronary heart disease in TCM syndrome differentiation, J Proteome Res, 18, 1994, 10.1021/acs.jproteome.8b00799 Wu, 2012, Application of metabolomics in traditional Chinese medicine differentiation of deficiency and excess syndromes in patients with diabetes mellitus, Evid Based Complement Alternat Med, 2012, 10.1155/2012/968083 Yang, 2019, Emerging applications of metabolomics in traditional Chinese medicine treating hypertension: biomarkers, pathways and more, Front Pharmacol, 10, 158, 10.3389/fphar.2019.00158 Chen, 2020, Innovative highlights of clinical drug trial design, Transl Res, 224, 71, 10.1016/j.trsl.2020.05.007 Zhou, 2017, The changing landscape of clinical trial and approval processes in China, Nat Rev Clin Oncol, 14, 577, 10.1038/nrclinonc.2017.10 Vetter, 2017, Defining the primary outcomes and justifying secondary outcomes of a study: usually, the fewer, the better, Anesth Analg, 125, 678, 10.1213/ANE.0000000000002224 van Wietmarschen, 2009, Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients, J Clin Rheumatol, 15, 330, 10.1097/RHU.0b013e3181ba3926 König, 2017, What is precision medicine?, Eur Respir J, 50, 1700391, 10.1183/13993003.00391-2017 Ramaswami, 2018, Precision medicine from a public health perspective, Annu Rev Public Health, 39, 153, 10.1146/annurev-publhealth-040617-014158 Wu, 2021, Exploring biological basis of syndrome differentiation in coronary heart disease patients with two distinct syndromes by integrated multi-omics and network pharmacology strategy, Chin Med, 16, 109, 10.1186/s13020-021-00521-3 Li, 2022, Application and prospect of platelet multi-omics technology in study of blood stasis syndrome, Chin J Integr Med, 28, 99, 10.1007/s11655-021-3349-y